Published in Healthcare Mergers, Acquisitions and Ventures Week, June 23rd, 2007
"For more than half a century, SRI has conducted basic and applied research in the discovery and development of new drugs. With three drugs on the market, four in various stages of clinical trials and five lead compounds in preclinical development, our success is clearly demonstrated by our pipeline,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week